How to Adjust Asthma Management Once Asthma Is Controlled on Long-Term Biologic Therapy

Area of Science:

• Allergy and immunology
• Pulmonary medicine
• Pharmacology

Background:

• Biologics targeting IgE, IL-5, IL-5 receptor, IL-4 receptor α, or thymic stromal lymphopoietin have significantly improved asthma outcomes.
• While effective, long-term biologic therapy presents challenges regarding cost and patient convenience.
• Patients often inquire about reducing medication intensity once asthma is controlled.

Purpose of the Study:

• To review the safety and efficacy of alternative asthma medication management strategies for patients on long-term biologic therapy.
• To evaluate options for reducing treatment burden while maintaining asthma control.

Main Methods:

• Review of existing data on various asthma medication management strategies.
• Evaluation of stopping biologics, stopping background therapy, dose reduction, interval extension, and seasonal administration.
• Assessment of safety and efficacy of these alternative regimens.

Main Results:

• Many patients may be able to safely adopt alternative regimens, potentially simplifying treatment and reducing costs.
• Strategies include discontinuing biologics, adjusting dosing intervals, or reducing dose frequency.
• Further research is necessary to define optimal patient selection and implementation protocols.

Conclusions:

• Alternative medication management strategies for asthma biologics are feasible for select patients.
• These approaches can enhance patient quality of life and reduce healthcare expenses.
• More research is needed to guide personalized application of these strategies.